AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSL LIMITED

262.000

-2.260-0.86%

Volume:756.66K

Turnover:198.19M

Market Cap:126.86B

PE:29.33

High:263.740

Open:263.740

Low:260.330

Close:264.260

Loading ...

Overview Company News Filings

CSL share price on watch amid $2.1b half year profit and dividend hike

Falling US flu vaccine rates hurt Australia's CSL profit growth

CSL Posts EPS of $4.13, Total Operating Revenue of $8.48 Billion in Half Year Ended Dec. 31, 2024

MT Newswires Live

CSL Lifts 1H Net Profit by 3%, Led by Blood-Plasma Business -- Update

ASX Market Open: Traders decide now-looming US steel, aluminium tariffs not quite so scary | Feb 11, 2025

The Market Herald

BRIEF-CSL Posts H1 Net Income Of USD 2,010 Million

Australia's CSL posts a 5% jump in first-half profit

CSL H1 Adjusted Net Income USD 2,070 Million

THOMSON REUTERS

CSL Interim Dividend of $1.30 per Share

THOMSON REUTERS

Low vaccination rates in the US dent CSL first-half sales

The West Australian

Vaccine fatigue weighs on CSL’s profits

Miners, banks drag Australian shares lower; muted corporate earnings expected

Two Contrarian Ideas for Australia's Earnings Season -- Market Talk

Former Investible CEO Rod Bristow to lead Breakthrough Victoria

Business News Australia

3 amazing Australian stocks to buy and hold until 2030

5 easy steps to making $1 million from ASX shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CSL.AU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":262,"timestamp":1741237920000,"preClose":264.26,"halted":0,"volume":756660,"delay":0,"changeRate":-0.008552,"change":-2.26,"floatShares":483945244,"shares":484206716,"eps":8.932402,"lyrEps":8.627969,"pbRate":4.33,"amount":198192052,"amplitude":0.012904,"volumeRatio":0.757239,"dividePrice":4.337758,"prevYearClose":281.58,"fiveDayClose":260.29,"twentyDayClose":272.87},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":483945244,"roa":"6.61%","roe":"14.35%","lyrEps":8.627969,"volumeRatio":0.757239,"shares":484206716,"dividePrice":4.337758,"high":263.74,"amplitude":0.012904,"preClose":264.26,"low":260.33,"week52Low":253.04,"pbRate":"4.33","psRate":"5.28","week52High":311.319,"institutionHeld":0,"latestPrice":262,"committee":0.125,"eps":8.932401950887112,"divideRate":0.016639,"volume":756660,"delay":0,"ttmEps":8.932401950887112,"open":263.74,"prevYearClose":281.58,"prevWeekClose":260.57,"prevMonthClose":260.57,"prevQuarterClose":281.58,"fiveDayClose":260.29,"twentyDayClose":272.87,"sixtyDayClose":280.82},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2025-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2025-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-11","defaultRemindTime":1741561200000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-09","payableDate":"2025-03-11","currency":"USD","dateTimestamp":1741525200000,"payDate":"2025-04-09"},{"date":"2025-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739228400000,"name":null,"time":"","dateTimestamp":1739192400000,"actualEps":null},{"date":"2024-09-09","symbol":"CSL.AU","amount":1.45,"announcedDate":"2024-08-13","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-10","defaultRemindTime":1725840000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-02","payableDate":"2024-09-10","currency":"USD","dateTimestamp":1725804000000,"payDate":"2024-10-02"},{"date":"2024-08-13","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723507200000,"name":null,"time":"","dateTimestamp":1723471200000,"actualEps":null},{"date":"2024-03-11","symbol":"CSL.AU","amount":1.19,"announcedDate":"2024-02-13","type":"dividend","market":"AU","newRecordDate":"2024-03-12","defaultRemindTime":1710111600000,"name":"CSL 公司","recordDate":"2024-04-03","payableDate":"2024-03-12","currency":"USD","dateTimestamp":1710075600000,"payDate":"2024-04-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:16,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2510811586","title":"CSL share price on watch amid $2.1b half year profit and dividend hike","url":"https://stock-news.laohu8.com/highlight/detail?id=2510811586","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510811586?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:48","pubTimestamp":1739224108,"startTime":"0","endTime":"0","summary":"The CSL Ltd  share price will be one to watch closely today. That's because the biotechnology giant has just released its half year results. Let's see how the widely followed company reported. CSL share price on watch following results release  Revenue up 5% in constant currency to US$8.48 billion Net profit after tax up 7% in constant currency to US$2.04 billion NPATA up 5% in constant currency to US$2.11 billion Reported NPATA up 3% to US$2.07 billion Interim dividend of US$1.30 per share  What happened during the half?This result appears to have fallen short of expectations, which could potentially be bad news for the CSL share price today. Goldman Sachs was forecasting total revenue of US$8.66 billion and NPATA of US$2.27 billion .Whereas it reported revenue of revenue of US$8.48 billion and constant curr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/11/csl-share-price-on-watch-amid-2-1b-half-year-profit-and-dividend-hike/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["CSL.AU","BK7511","BK4086","LU0728928796.USD","BK7508","LU1169590202.USD","BK7501","SGXZ23171101.USD","BK7067","CSL","LU1169589451.USD","SG9999004303.SGD"],"gpt_icon":1},{"id":"2510438813","title":"Falling US flu vaccine rates hurt Australia's CSL profit growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2510438813","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510438813?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:45","pubTimestamp":1739223937,"startTime":"0","endTime":"0","summary":"UPDATE 4-Falling US flu vaccine rates hurt Australia's CSL profit growthAdds additional quotes from CEO and contextBy Christine ChenFeb 11 (Reuters) - Australian biopharmaceutical company CSL said on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nL4N3P11PL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","SG9999014906.USD","LU0154236417.USD","LU1989763005.USD","SG9999014880.SGD","GB00BDT5M118.USD","BK4597","LU2210150020.SGD","LU2264538146.SGD","SPGI","BK4112","LU2764263039.SGD","BK4581","BK7511","SG9999001077.SGD","LU0097036916.USD","LU2720916845.USD","BK7067","LU2095319765.USD","BK7508","LU0354030438.USD","SG9999018865.SGD","SG9999014898.SGD","LU2028103732.USD","LU0345774631.USD","LU0158827781.USD","LU1804176565.USD","LU0354030511.USD","SG9999017495.SGD","BK4534","LU1988902786.USD","BK4566","IE00B19Z9505.USD","LU1989772840.SGD","LU0985320562.USD","LU2764263203.CNY","LU0345774391.USD","LU0342679015.USD","LU2265009873.SGD","LU1633808545.USD","LU1363072403.SGD","LU2210149790.SGD","CSL.AU","LU1064131342.USD","BK4588","LU1989773731.SGD","LU2089283258.USD","LU2023251221.USD","LU0158827948.USD","LU2764262908.HKD"],"gpt_icon":0},{"id":"2510813683","title":"CSL Posts EPS of $4.13, Total Operating Revenue of $8.48 Billion in Half Year Ended Dec. 31, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2510813683","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510813683?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:40","pubTimestamp":1739223646,"startTime":"0","endTime":"0","summary":"CSL Posts EPS of $4.13, Total Operating Revenue of $8.48 Billion in Half Year Ended Dec. 31, 2024","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL","CSL.AU","TSS"],"gpt_icon":0},{"id":"2510581321","title":"CSL Lifts 1H Net Profit by 3%, Led by Blood-Plasma Business -- Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2510581321","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510581321?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:40","pubTimestamp":1739223600,"startTime":"0","endTime":"0","summary":"Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business.Australia-based CSL, which runs a network of plasma-collection centers in the U.S., said its net profit totaled US$2.07 billion in the six months ended Dec. 31. That compared to a US$2.02 billion profit in the year-prior period and market expectations of US$2.09 billion, according to Visible Alpha.The company declared an interim dividend of US$1.30 per share, compared to US$1.19 a year ago.When foreign-exchange movements were stripped out, CSL's profit rose by 5% to US$2.11 billion.It reaffirmed guidance for annual net profit of US$3.2 billion-US$3.3 billion at constant exchange rates. If achieved, that would represent growth of 10-13% on the 2024 fiscal year.CSL said the half-year result reflected the continued strong performance of its CSL Behring unit, especially immunoglobulins, a key substance collected from plasma.\"In CSL Behring we will","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4086","CSL.AU","BK7511","BK7501","CSL","LU1169590202.USD","BK7508","LU1169589451.USD","SGXZ23171101.USD","SG9999004303.SGD","BK7067","LU0728928796.USD"],"gpt_icon":0},{"id":"2510810152","title":"ASX Market Open: Traders decide now-looming US steel, aluminium tariffs not quite so scary | Feb 11, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2510810152","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510810152?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:34","pubTimestamp":1739223240,"startTime":"0","endTime":"0","summary":"The local bourse is headed for a green open, with the ASX 200 futures now pointing to a 0.22% rise – to a hair over 8,500 points – as global traders shrug at Trump’s steel and aluminium tariffs in a way Australia didn’t yesterday.While there were some panics Down Under following the news on Monday, the reports have done little to knock U.S. sentiments as Week 7 trade starts there.Instead, Wall Street is said to be “looking at the light at the end of the tunnel.”Back home, Westpac  and NAB  are both releasing February consumer confidence reports – the first is at 10.30am; the second an hour later.Elsewhere, Fortescue’s  off-market takeover bid for all shares in Red Hawk Mining  has been affirmed as unconditional.HotCopper forum users also watch Vulcan Energy  after the energy and lithium producer slashed its interim dividend. The decision comes after earnings dropped 31% amid “headwinds” for the NZ company.That’s Market Open, I’m Isaac McIntyre, stick with us for HotCopper’s Market Upda","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-open-traders-decide-now-looming-us-steel-aluminium-tariffs-not-quite-so-scary-feb-11-2025-2025-02-11/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7135","BK7507","BK7501","BRG.AU","BK7052","RHK.AU","BK7511","SWM.AU","BK7120","FMG.AU","BK7031","CSL.AU","BK7508","BK7129","SGH.AU","NAB.AU","BK7119","BK7067","BK7095","VUL.AU","WBC.AU","BK7504"],"gpt_icon":0},{"id":"2510185628","title":"BRIEF-CSL Posts H1 Net Income Of USD 2,010 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2510185628","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510185628?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:24","pubTimestamp":1739222683,"startTime":"0","endTime":"0","summary":"BRIEF-CSL Posts H1 Net Income Of USD 2,010 Million\n\n\nFeb 11 (Reuters) - CSL H1 net income USD 2,010 million.\n\nH1 revenue USD 8,480 million\nH1 adjusted net income USD 2,070 million\nCSL INTERIM DIVIDEND OF $1.30 PER SHARE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nPLX150E0E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7511","BK7508","BK7501","BK7067"],"gpt_icon":0},{"id":"2510818870","title":"Australia's CSL posts a 5% jump in first-half profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2510818870","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510818870?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:20","pubTimestamp":1739222442,"startTime":"0","endTime":"0","summary":"Australia's CSL posts a 5% jump in first-half profitFeb 11  - Australia's CSL Ltd CSL.AX reported a 5% rise in its first-half profit on Tuesday, boosted by growth in its core immunoglobulin business across geographies.The biotech giant said that its underlying net profit after tax attributable for the six months ended December 31 was $2.11 billion, on a constant currency basis, compared with $2.06 billion reported a year ago.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nL4N3P11OX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7501","BK7508","BK7511","BK7067"],"gpt_icon":0},{"id":"2510890962","title":"CSL H1 Adjusted Net Income USD 2,070 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2510890962","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510890962?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:10","pubTimestamp":1739221839,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nPLX150E0E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7067","BK7508","CSL.AU","BK7501"],"gpt_icon":0},{"id":"2510890926","title":"CSL Interim Dividend of $1.30 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2510890926","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510890926?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:10","pubTimestamp":1739221839,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nPLX150E0E:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","CSL.AU","BK7511","BK7508","BK7067"],"gpt_icon":0},{"id":"2510464018","title":"Low vaccination rates in the US dent CSL first-half sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2510464018","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510464018?lang=en_us&edition=fundamental","pubTime":"2025-02-11 01:11","pubTimestamp":1739207516,"startTime":"0","endTime":"0","summary":"Low immunisation rates in the US have dented first-half sales for CSL’s flu vaccine business, but the biotech giant says it’s on track to deliver double-digit earnings growth this year.","market":"hk","thumbnail":"https://images.thewest.com.au/publication/C-17680580/33cc698ff9c7a6fa116c82bac8e2b1efd8532479.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-17680580/33cc698ff9c7a6fa116c82bac8e2b1efd8532479.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/biotech/biotech-giant-csl-still-expects-double-digit-earnings-growth-despite-weak-flu-vaccine-sales-c-17680580","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/biotech/biotech-giant-csl-still-expects-double-digit-earnings-growth-despite-weak-flu-vaccine-sales-c-17680580","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["CSL","CSL.AU"],"gpt_icon":0},{"id":"2510576365","title":"Vaccine fatigue weighs on CSL’s profits","url":"https://stock-news.laohu8.com/highlight/detail?id=2510576365","media":"Commsec","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510576365?lang=en_us&edition=fundamental","pubTime":"2025-02-11 00:00","pubTimestamp":1739203200,"startTime":"0","endTime":"0","summary":"CSL Limited (CSL) posted its half year results, with both its revenue and profit outcomes falling short of consensus. It has maintained its full year guidance. ","market":"us","thumbnail":"https://www.commsec.com.au/content/dam/EN/Images/CommSec%20Public/card/CSL_card_312x176.jpg","type":0,"news_type":0,"thumbnails":["https://www.commsec.com.au/content/dam/EN/Images/CommSec%20Public/card/CSL_card_312x176.jpg"],"rights":{"source":"commsec_stock","url":"https://www.commsec.com.au/market-news/reporting-season/feb-25/csl-ltd-half-year-result-2025.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.commsec.com.au/market-news/reporting-season/feb-25/csl-ltd-half-year-result-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"commsec_stock","symbols":["CSL","BK7511","BK4086","BK7508","LU0728928796.USD","LU1169589451.USD","BK7501","SG9999004303.SGD","SGXZ23171101.USD","BK7067","CSL.AU","LU1169590202.USD"],"gpt_icon":0},{"id":"2510888866","title":"Miners, banks drag Australian shares lower; muted corporate earnings expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2510888866","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510888866?lang=en_us&edition=fundamental","pubTime":"2025-02-10 13:50","pubTimestamp":1739166624,"startTime":"0","endTime":"0","summary":"Miners, banks drag Australian shares lower; muted corporate earnings expectedAXJO extends losses from FridayWisetech Global top loser on ASX 200CBA and CSL among companies due to report earnings this weekBy Roshan Thomas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nL4N3P10CF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMG.AU","AN3PL.AU","WTC.AU","RIO.UK","ANZ.AU","CSL.AU","NAB.AU","BHP.AU"],"gpt_icon":0},{"id":"2510754890","title":"Two Contrarian Ideas for Australia's Earnings Season -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2510754890","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510754890?lang=en_us&edition=fundamental","pubTime":"2025-02-10 07:38","pubTimestamp":1739144280,"startTime":"0","endTime":"0","summary":"2338 GMT - Macquarie serves up two contrarian ideas for investors as Australia's corporate-earnings season extends into its second week. It believes the market likely fears a CSL miss, given the pharmaceutical company's stock hasn't yet arrested a share-price slide that began in July and some analysts have cut forecasts. CSL's stock is down some 13% since July 23. \"It should benefit from the lower AUD and pharma tends to outperform after RBA cuts,\" Macquarie says. Many economists expect Australia's central bank to cut interest rates this month, which would be the first time since inflation ran hot in the pandemic's aftermath. Macquarie is also bullish about property company Mirvac, saying it would also benefit from rate cuts. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","MGR.AU"],"gpt_icon":0},{"id":"2510844201","title":"Former Investible CEO Rod Bristow to lead Breakthrough Victoria","url":"https://stock-news.laohu8.com/highlight/detail?id=2510844201","media":"Business News Australia","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510844201?lang=en_us&edition=fundamental","pubTime":"2025-02-10 00:00","pubTimestamp":1739116800,"startTime":"0","endTime":"0","summary":"The Victorian State Government's private investment company tha...","market":null,"thumbnail":"https://assets.cdn.thewebconsole.com/S3WEB6082/a_images/67a98abdc07f0.jpg?v=2&m=5e9102f7e5be869756f1f133191f247e&lqip(10)","type":0,"news_type":0,"thumbnails":["https://assets.cdn.thewebconsole.com/S3WEB6082/a_images/67a98abdc07f0.jpg?v=2&m=5e9102f7e5be869756f1f133191f247e&lqip(10)"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businessnewsaustralia.com/articles/former-investible-ceo-rod-bristow-to-lead-breakthrough-victoria.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"businessau_stock","symbols":["BK7511","BK7508","CSL.AU","BK7501","BK7067"],"gpt_icon":0},{"id":"2509779973","title":"3 amazing Australian stocks to buy and hold until 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2509779973","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509779973?lang=en_us&edition=fundamental","pubTime":"2025-02-08 04:18","pubTimestamp":1738959480,"startTime":"0","endTime":"0","summary":"I believe that one of the simplest and most effective ways of building wealth in the share market is through buy and hold investing. Instead of trying to time the market or jump in and out of stocks, ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/08/3-amazing-australian-stocks-to-buy-and-hold-until-2030/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["IE00BZ1G4Q59.USD","LU2357305700.SGD","XAO.AU","BK4504","LIF","LU0912757837.SGD","LU2111349929.HKD","XJO.AU","LU2271345857.HKD","LU0320765646.SGD","LU2347655156.SGD","360.AU","BK4581","BK7511","LU0314104364.USD","LU1720051108.HKD","BK7067","LU1732800096.USD","LU1162221912.USD","BK7508","LU0106831901.USD","BK4127","BK7016","BK7503","LU2133065610.SGD","LU0106261372.USD","LU1720051017.SGD","LU0158827781.USD","BK4534","LU1074936037.SGD","LU1989772840.SGD","WTC.AU","LU0795875086.SGD","LU0158827948.USD","LU0795875169.SGD","XKO.AU","LU1989772923.USD","LU2089284900.SGD","LU0971096721.USD","BK4023","LU1668664300.SGD","LU0098860793.USD","IE00BKVL7J92.USD","CSL.AU","LU1732799900.SGD","BK4588","LU0225283273.USD","LU2089283258.USD","LU2023251221.USD","BK7501"],"gpt_icon":0},{"id":"2509778239","title":"5 easy steps to making $1 million from ASX shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2509778239","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509778239?lang=en_us&edition=fundamental","pubTime":"2025-02-08 02:35","pubTimestamp":1738953300,"startTime":"0","endTime":"0","summary":"Investing in the share market can be one of the most effective ways to build long-term wealth, and with the right strategy, reaching $1 million is very achievable. But success doesn't happen overnight","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/08/5-easy-steps-to-making-1-million-from-asx-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7042","BK7153","BK7501","WES.AU","CSL.AU","BK7510","BK7511","BK7508","TLS.AU","BK7067","BK7155","RMD.AU","BK7007","BK7099","GMG.AU","BK7041"],"gpt_icon":1}],"pageSize":16,"totalPage":13,"pageCount":4,"totalSize":200}]}}